CAS 1374248-77-7 appears in our catalog under these names: Ubrogepant, Ubrogepant/ 99.79% (existing batch purity), Ubrogepant (MK–1602), Ubrogepant, 99.90%, (3′S)-1′,2′,5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxospiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 99%, 99%. Offered by: Chemat Brand, TargetMol, GLPBio, Biosynth, MedChemExpress. Available pack sizes: on request, 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso).
Ubrogepant is an oral CGRP (Calcitonin Gene-Related Peptide Receptor ) antagonist used in the acute treatment of migraine with or without aura.
Source: ChEBI
| Molecular formula | C29H26F3N5O3 |
|---|---|
| Molecular weight | 549.5 g/mol |
| IUPAC name | (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide |
| InChIKey | DDOOFTLHJSMHLN-ZQHRPCGSSA-N |
| SMILES | C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6 |
Computed by PubChem (NCBI)